Two ways to control pain after total shoulder surgery for shoulder osteoarthritis
Compares a nerve catheter with a single Exparel injection for pain after shoulder replacement.
Key facts
- Who runs it
- Melinda Seering
- Where
- Iowa City, United StatesSee the site
- Trial code
- Registry title
- Comparison of Interscalene Catheter to Single Injection Interscalene Blocks for Total Shoulder Arthroplasties
- Status
- Recruiting
- Phase
- Phase 4
- People taking part
- 56 people, planned
- Started
- 19 Aug 2024
- Expected to end
- Jan 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Interscalene Catheter
- Exparel Single Shot Interscalene Block
- Record updated
- 10 November 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults having planned reverse shoulder replacement surgery. It compares two ways of numbing the nerves of the shoulder to control pain after surgery.
- Age
- 18 Years to 90 Years (at least 18 and less than 90 years old).
- Sex
- All sexes can join.
- Disease stage
- Planned, non-emergency reverse shoulder replacement surgery with the orthopedics service. ASA class I, II, or III (a score of general health before anesthesia).
- Earlier treatment
- People who regularly took opioid pain medicine before surgery (greater than 20 MME) cannot join. People having a repeat (revision) shoulder surgery cannot join.
Main reasons for not taking part
- Taking blood thinners or other reasons a nerve block cannot be done
- Serious lung disease, or allergy to Exparel, Bupivacaine or Ropivacaine
- Nerve damage (neuropathy) in the arm to be numbed
- Documented kidney failure or liver failure
- Pregnancy, a shoulder fracture, or being unable to communicate in English
The registry criteria, word for word
Show all 20 criteriaShow less
Who can take part
- Patients who have or are:
- Orthopedics service patients having reverse shoulder replacement surgery
- ASA class I, II, or III
- Patients at least 18 years old but less than 90 years old
- Patients giving informed consent
- Non-Emergency Surgery
Who cannot take part
- Revision surgery
- Significant pulmonary disease or allergy to medications used for peripheral nerve blocks (Exparel, Bupivacaine and Ropivacaine)
- Documented Kidney Failure
- Documented Liver Failure
- Patients who have or are:
- An inability to cooperate during the block placement
- Patients who do not meet criteria for a regional block: such as those on anti-coagulation,
- Neuropathy of the planned extremity to block
- A lack of or inability to give informed consent
- Currently incarcerated
- Pregnant
- Unable to communicate in English
- Chronic pre-operative opioid use (greater than 20 MME opioid used)
- Fracture
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 90 years old?
Where in United States
- University of Iowa Hospital and ClinicsIowa City, United StatesContact: Melinda Seering, M.D.Taking people
About the trial
What the trial wants to find out
Comparison of post-operative pain after total shoulder surgery. The Principle Investigator will be comparing Exparel single shot block to Interscalene catheter
The 2 groups in the trial
- Interscalene CatheterExisting treatment, for comparison
One of the current standard of care for shoulder replacement surgery at our institution is to receive an interscalene catheter for pre-operatively
- Exparel Single Shot Interscalene BlockExisting treatment, for comparison
One of the current standard of care for shoulder replacement surgery at our institution is to receive a pre-operative single shot interscalene block with Exparel
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- A Feasibility Randomized Control Comparison of Peripheral Interscalene Catheter to Liposomal Bupivacaine Single Injection for Interscalene Blocks Used in Pain Control for Total Shoulder Arthroplasties
- Plain-language title
- Two ways to control pain after total shoulder surgery for shoulder osteoarthritisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT05868330, who can take part
- Record updated
- 10 November 2025